The cannabis industry has become a hearth of massive growth over the past several years with new legislation going into place in and around the nation. The industry continues to show massive amount of potential as new products are pushed forward and old ones are developed to a greater degree. With the amount of innovation occurring in the market, it seems only fair that many of the most popular companies are continuing to take in massive gains throughout the industry.

One of the most obvious ways to get involved in the investment side of the cannabis market comes from the producers of the raw cannabis plant. The largest stock in the industry has continued to be Canopy Growth (NYSE:CGC). Canopy Growth has become the first of its kind in the industry due to their listing on the prestigious New York Stock Exchange not too long ago. This is one of the first times that a cannabis company has been listed on such a large exchange, and continues to help the shifting paradigm towards positive remarks about the market. The company recently gave Constellation Brands, a large beverage producer in the nation, a 9.9% stake in the company, helping to show how much promise they have for the future.

Right behind Canopy is the large Canadian producer of cannabis, Aurora Cannabis (OTCMKTS: ACBFF). The company recently completed the largest acquisition in the history of the market with their purchase of the cannabis producer CanniMed. The combination of the two companies has helped to produce more probability for the company becoming one of the larger guys in the industry (more than it already is) and staying there in the future.

For those looking to get into the ancillary industry of the cannabis market, there are many options throughout the industry. The Canadian based company, Namaste Technologies (OTCMKTS:NXTFF) is currently valued at around $300 million and manufacturers papers, pipes and anything else that those who consume cannabis could need to do just that.

The other side of the ancillary industry dealing with cannabis goes to that of the pharmaceutical side of the market. One of the larger producers and manufactures of pharmaceuticals using cannabis continues to be Zynerba Pharmaceuticals NASDAQ:ZYNE). The company has been working to research the effects of cannabis for many rare conditions that individuals may have. Cannabis has been proven time and time again as a viable treatment for a very wide range of ailments, and thus Zynerba has worked to capitalize on this by producing some of the newest and most cutting-edge medical products in the industry. The company is currently working to find approval for some of their studies and potential drugs they would like to have on the market, but they are still some time away from this becoming a reality. The other big pharmaceuticals company in the industry has continued to be GW Pharmaceuticals (NASDAQ:GWPH). GW has worked to become the main producer of cannabis-related drugs in the industry and recently was just approved by the Food and Drug Administration to produce their drug known as Epidiolex for the public.

The cannabis industry in itself is still very much in the infant stages of growth in the market, which means that there is a large amount of room to continue building the market as we move toward the future. The hopes are high that companies like the ones mentioned above, will continue to cement innovation and new ideas throughout the market. Only time will tell how well this effort will continue to work as we move toward the next few years.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published.

You May Also Like